Key facts for DRG 840
- FY2027 relative weight
- 3.2740
- Higher than 81% of all MS-DRGs
- Change vs FY2026
- +1.2%
- FY2026 weight 3.2350
- Geometric mean LOS
- 6.7 days
- Arithmetic mean 9.6 days
- MDC
- 17
- Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms
- Severity level
- with MCC (major complication or comorbidity)
- Transfer policy
- Post-acute transfer DRG
TL;DR
MS-DRG 840 is a medical group in MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms) at the highest-severity level of its family. CMS assigns it a FY2027 relative weight of 3.2740 with a geometric mean length of stay of 6.7 days and an arithmetic mean of 9.6. Its weight moved up 1.2% from FY2026 (3.2350). That weight is higher than 81% of all medical and surgical MS-DRGs. Its CC/MCC family (DRG 841, DRG 842) spans weights 0.9950 to 3.2740. The v44 Definitions Manual assigns it through 519 principal diagnosis codes.
What changed from FY2026 to FY2027
CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 840 the FY2027 relative weight is 3.2740 against 3.2350 in FY2026, a rise of 1.21%.
| Metric | FY2026 | FY2027 | Change |
|---|---|---|---|
| Relative weight | 3.2350 | 3.2740 | +0.0390 |
| Geometric mean LOS (days) | 6.8 | 6.7 | -0.1 |
| Arithmetic mean LOS (days) | 9.7 | 9.6 | -0.1 |
CC and MCC family
DRG 840 shares its base definition with 2 other MS-DRGs split by severity. The family's weights span 0.9950 to 3.2740, a 3.29× spread, which is the payment effect of documenting qualifying complications and comorbidities.
Grouper logic (v44 Definitions Manual)
Principal Diagnosis: 519 ICD-10 codes drive assignment to this group; the first 12 are shown.
| ICD-10 code | Description |
|---|---|
| C261 | Malignant neoplasm of spleen |
| C463 | Kaposi's sarcoma of lymph nodes |
| C770 | Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck |
| C771 | Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes |
| C772 | Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes |
| C773 | Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes |
| C774 | Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes |
| C775 | Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes |
| C778 | Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions |
| C779 | Secondary and unspecified malignant neoplasm of lymph node, unspecified |
| C7B01 | Secondary carcinoid tumors of distant lymph nodes |
| C8100 | Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site |
Documentation and denial exposure
As a medical DRG, assignment depends on the principal diagnosis sequenced from the attending's documentation; a secondary condition sequenced first, or a symptom code in place of the confirmed diagnosis, changes the MDC or the DRG. Because this family splits by severity, auditors target CC and MCC capture: each secondary diagnosis must be documented as present, monitored, evaluated or treated during the stay to survive a DRG-validation review. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).
How QuickIntell uses DRG 840 data
QuickCode groups inpatient encounters against the current v44 logic, flags CC and MCC candidates that lack supporting documentation, and shows the weight difference across the family before the claim drops. QuickScribe captures the attending's language that supports severity, and QuickRCM works DRG-validation denials with the grouper evidence attached.
Frequently asked questions — DRG 840
What is MS-DRG 840?
MS-DRG 840 is "Lymphoma and Non-Acute Leukemia with MCC", a medical Medicare Severity Diagnosis-Related Group in MDC 17, Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms. Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.
What is the FY2027 relative weight for DRG 840?
The FY2027 relative weight is 3.2740 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 3.2350, a change of +1.2%.
What is the average length of stay for DRG 840?
CMS reports a geometric mean length of stay of 6.7 days and an arithmetic mean of 9.6 days for FY2027. The geometric mean is used for transfer-payment calculations.
Which DRGs are in the same CC/MCC family as 840?
DRG 841 (Lymphoma and Non-Acute Leukemia with CC, weight 1.5770); DRG 842 (Lymphoma and Non-Acute Leukemia without CC/MCC, weight 0.9950). The family's weights range from 0.9950 to 3.2740, so documented complications and comorbidities change payment materially.
What documentation supports the severity level of DRG 840?
DRG 840 requires at least one secondary diagnosis on the CMS Major Complication or Comorbidity list, documented as present and clinically addressed during the stay (monitored, evaluated, treated or extending the stay). Conditions such as acute respiratory failure, severe sepsis or acute kidney injury with specified cause qualify only when the attending's note states the diagnosis itself, not just the lab values. Recovery auditors downgrade this group to the CC or base level when the MCC rests on an unconfirmed query or a resolved historical condition, so the query response and the discharge summary must agree.
Which codes group to DRG 840?
The v44 Definitions Manual lists 519 principal diagnosis codes for this group. Examples from the principal diagnosis list: C261 (Malignant neoplasm of spleen); C463 (Kaposi's sarcoma of lymph nodes); C770 (Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck); C771 (Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes).
Is DRG 840 a post-acute transfer DRG?
Yes. CMS flags DRG 840 under the post-acute care transfer policy, so a discharge to a qualifying post-acute setting before the geometric mean length of stay is paid a per-diem amount rather than the full DRG payment.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-01. Verify against the primary file before billing or contracting decisions.
- IPPS FY2027 Final Rule Table 5 (CMS-1849-F)Version v44 FY2027 · effective 2026-10-01 · file CMS-1849-F Table 5.txtSHA-256 01003dd571c1e2f5…
- IPPS FY2026 Final Rule Table 5 (CMS-1833-F)Version v43 FY2026 · effective 2025-10-01 · file CMS-1833-F Table 5.txtSHA-256 bf8c390d14b3cd3e…
- ICD-10 MS-DRG Definitions Manual v44 (text)Version v44 · effective 2026-10-01 · file fy2027-fr-icd10-ms-drg-definitions-manual-files-v44.zipSHA-256 ae4f6c11727fe91f…
Disclaimer
This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.